Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
doxorubicin hydrochloride injection
DRUG
2 trials
Sponsors
University Health Network, Toronto
, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Advanced Endometrial Cancer
Advanced Solid Tumours
Sarcoma of Uterus
Phase 1
Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours
Completed
NCT01163903
University Health Network, Toronto
Advanced Solid Tumours
Start: 2010-07-31
End: 2015-05-31
Updated: 2015-07-15
Phase 2
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Terminated
NCT05481645
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Endometrial Cancer, Sarcoma of Uterus
Start: 2022-08-26
End: 2025-11-30
Updated: 2026-01-09
Related Papers
Benmelstobart plus carboplatin/paclitaxel with or without anlotinib, followed by maintenance benmelstobart with or without anlotinib, as first-line treatment for advanced or recurrent endometrial cancer: A randomized, open-label, phase II trial.
Journal of Clinical Oncology
2025-05-28